FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama
An FDA advisory committee has unanimously recommended the approval of Moderna's mRNA influenza vaccine for older adults.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A federal vaccine panel voted unanimously to recommend the authorization of Moderna’s mRNA-based flu vaccine. This decision marks the first time such an advisory committee has recommended a vaccine since 2023. The shot is intended for use in older adult populations.
Coverage from CIDRAP, NPR, Stat News, FirstWord Pharma, WRAL, NBC News, and Ars Technica emphasizes the unanimous nature of the vote. Reports also note that the approval process followed a period of agency drama and controversy surrounding the vaccine. Next steps involve the formal FDA regulatory process following this panel endorsement.
Coverage does not yet specify a final timeline for the vaccine's availability.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 150d ago.
Quick answers
Who is the vaccine for?
According to NBC News, the vaccine is intended for older adults.
What technology does the vaccine use?
The vaccine utilizes mRNA technology, described by reporting as first-of-its-kind for a flu shot.
Was the committee vote divided?
No, multiple outlets including Ars Technica and NPR report the vote was unanimous.
Coverage (7)
- Moderna’s mRNA flu vaccine gets thumbs up from federal vaccine panel CIDRAP · 152d ago
- Key FDA committee unanimously recommends its first vaccine since 2023 NPR · 152d ago
- FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy statnews.com · 152d ago
- FDA panel strongly backs Moderna's mRNA flu vaccine FirstWord Pharma · 152d ago
- FDA panel considers a first-of-its-kind flu vaccine using mRNA technology WRAL · 152d ago
- FDA panel recommends Moderna’s mRNA flu shot for older adults NBC News · 152d ago
- FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama Ars Technica · 152d ago
Topics
Related trends
Roche Secures First U.S. Approval for New Breast-Cancer Pill
Roche wins FDA approval for its first U.S. oral SERD, giredestrant plus everolimus, for hormone-resistant advanced breast cancer.
More people are getting the flu. Should you get a flu shot before you travel?
Multiple U.S. outlets publish coordinated flu-shot guidance as seasonal influenza activity rises ahead of holiday travel.
A High-Dose Flu Vaccine Is Linked to Nearly 55% Lower Alzheimer's Risk
New scientific findings reveal a potential connection between the high-dose influenza vaccine and a significantly lower risk of developing Alzheimer's disease.
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Novo Nordisk reports Wegovy injection reduced BMI and obesity rates in children as young as six in a clinical trial, expanding the drug's potential pediatric use.
The GLP-1 boom has a dark side
FDA orders new eye-risk warnings on a dozen GLP-1 drugs, including Ozempic and Zepbound, amid reports of vision-threatening events.
Have the sniffles? See if respiratory illnesses are rising near you
U.S. flu season surges more than two months early with seven states reporting high activity and pediatric deaths rising ahead of Thanksgiving travel.